CYP19A1 - cytochrome P450 family 19 subfamily A member 1 Gene
Also Known as ARO; ARO1; CPV1; CYAR; CYP19; CYPXIX; P-450AROM
Species: Homo sapiens
About CYP19A1
This gene has 19 transcripts (splice variants), 319 orthologues, 12 paralogues and is associated with 4 phenotypes. Restricted expression toward placenta (RPKM 83.2).
Summary
This gene encodes a member of the Cytochrome P450 superfamily of Enzymes. The Cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of Cholesterol, Steroids and Other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
CYP19A1 Products (11)
| mRNA | Protein | Name |
|---|---|---|
| NM_000103.4 | NP_000094.2 | aromatase |
| NM_031226.3 | NP_112503.1 | aromatase |
| NM_001347250.2 | NP_001334179.1 | aromatase |
| NM_001347255.2 | NP_001334184.1 | aromatase |
| NM_001347249.2 | NP_001334178.1 | aromatase |
| NM_001347252.2 | NP_001334181.1 | aromatase |
| NM_001347254.2 | NP_001334183.1 | aromatase |
| NM_001347253.2 | NP_001334182.1 | aromatase |
| NM_001347256.2 | NP_001334185.1 | aromatase |
| NM_001347251.2 | NP_001334180.1 | aromatase |
| NM_001347248.1 | NP_001334177.1 | aromatase |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables aromatase activity |
IDA
IDA: Inferred from direct assay
|
19129847 | GOA |
| enables heme binding |
IDA
IDA: Inferred from direct assay
|
19129847 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in androgen catabolic process |
IDA
IDA: Inferred from direct assay
|
26482249 | GOA |
| involved in positive regulation of estradiol secretion |
IDA
IDA: Inferred from direct assay
|
26482249 | GOA |
CYP19A1 Protein Structure
p450: Cytochrome P450 (50 - 484)
- 0
- 100
- 200
- 300
- 400
- 503 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
aromatase |
|
|
CYP19A1 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P80547 | Aromatase Antibody (YA611) | WB, IP | Human, Mouse, Rat |
| HY-P80547A | Aromatase Antibody (YA611)(PBS only) | WB, IP | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Ovarian Cancer |
|
|
| Ovarian Benign Neoplasm |
|
|
| Androgen Insensitivity, Partial |
|
|
| Anovulation |
|
|
| Breast Lobular Carcinoma |
|
|
| Estrogen-Receptor Negative Breast Cancer |
|
|
| Endometrial Cancer |
|
|
| Breast Disease |
|
|
| Smith-Lemli-Opitz Syndrome |
|
|
| Estrogen Excess |
|
|
| Ovarian Cyst |
|
|
| Endometrial Stromal Sarcoma |
|
|
| Acne |
|
|
| Ovarian Hyperstimulation Syndrome |
|
|
| Diabetes Mellitus |
|
|
| Lobular Neoplasia |
|
|
| Infertility |
|
|
| Cytochrome P450 Oxidoreductase Deficiency |
|
|
| Breast Adenocarcinoma |
|
|
| Pseudohermaphroditism |
|
|
| Leydig Cell Tumor |
|
|
| Peutz-Jeghers Syndrome |
|
|
| Reproductive Organ Benign Neoplasm |
|
|
| Subserous Uterine Fibroid |
|
|
| Vaginal Benign Neoplasm |
|
|
| Vaginal Adenoma |
|
|
| Leiomyoma |
|
|
| Postmenopausal Atrophic Vaginitis |
|
|
| Endometrial Hyperplasia |
|
|
| Choriocarcinoma |
|
|
| Hermaphroditism |
|
|
| Vaginal Discharge |
|
|
| Testicular Disease |
|
|
| 46,Xy Sex Reversal 2 |
|
|
| Sex Cord-Gonadal Stromal Tumor |
|
|
| Amenorrhea |
|
|
| Asperger Syndrome |
|
|
| Thoracic Benign Neoplasm |
|
|
| De Quervain Disease |
|
|
| Ovarian Disease |
|
|
| Peritoneal Benign Neoplasm |
|
|
| Uterine Anomalies |
|
|
| Lipoid Congenital Adrenal Hyperplasia |
|
|
| Hypogonadism |
|
|
| Progesterone-Receptor Positive Breast Cancer |
|
|
| Hereditary Breast Ovarian Cancer Syndrome |
|
|
| Gestational Choriocarcinoma |
|
|
| Osteoporosis |
|
|
| Estrogen Resistance |
|
|
| Polycystic Ovary Syndrome |
|
|
| Hydronephrosis |
|
|
| Testicular Cancer |
|
|
| Prostate Disease |
|
|
| Steroid Inherited Metabolic Disorder |
|
|
| Luteoma |
|
|
| Estrogen-Receptor Positive Breast Cancer |
|
|
| Mycetoma |
|
|
| Prolactinoma |
|
|
| Gynecomastia |
|
|
| Myoma |
|
|
| Sertoli Cell Tumor |
|
|
| Hypogonadotropic Hypogonadism |
|
|
| Gender Incongruence |
|
|
| In Situ Carcinoma |
|
|
| Amelogenesis Imperfecta, Type Ig |
|
|
| Blepharophimosis, Ptosis, And Epicanthus Inversus |
|
|
| Complete Androgen Insensitivity Syndrome |
|
|
| Thrombocytopenia |
|
|
| Antley-Bixler Syndrome |
|
|
| Breast Carcinoma In Situ |
|
|
| Uterine Sarcoma |
|
|
| Hypertrophy Of Breast |
|
|
| Aromatase Deficiency |
|
|
| Male Infertility |
|
|
| Sebaceous Gland Disease |
|
|
| Hepatocellular Carcinoma |
|
|
| Body Mass Index Quantitative Trait Locus 11 |
|
|
| Breast Cancer |
|
|
| Stuttering |
|
|
| Schizophrenia 16 |
|
|
| Endometriosis |
|
|
| Pre-Malignant Neoplasm |
|
|
| Fallopian Tube Clear Cell Adenocarcinoma |
|
|
| Aromatase Excess Syndrome |
|
|
| Amelogenesis Imperfecta |
|
|
| Hyperandrogenism |
|
|
| Adrenal Cortical Carcinoma |
|
|
| Alopecia, Androgenetic, 1 |
|
|
| Bilateral Breast Cancer |
|
|
| Endometriosis Of Ovary |
|
|
| Disorder Of Sexual Development |
|
|
| Diffuse Peritoneal Leiomyomatosis |
|
|
| Female Breast Cancer |
|
|
| Leiomyoma, Uterine |
|
|
| Breast Ductal Carcinoma |
|
|
| Alopecia |
|
|
| Teeth Hard Tissue Disease |
|
|
| Precocious Puberty, Male-Limited |
|
|
| 46,Xy Sex Reversal |
|
|
| Bone Disease |
|
|
| Uterine Benign Neoplasm |
|
|
| Breast Benign Neoplasm |
|
|
| Premature Menopause |
|
|
| Ductal Carcinoma In Situ |
|
|
| Placental Choriocarcinoma |
|
|
| Adenomyosis |
|
|
| Prostate Cancer |
|
|
| Cryptorchidism, Unilateral Or Bilateral |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Felis catus | CYP19A1 | VGNC | VGNC:103332 |
| Bos taurus | CYP19A1 | VGNC | VGNC:110231 |
| Rattus norvegicus | CYP19A1 | RGD | RGD:2457 |
| Macaca mulatta | CYP19A1 | VGNC | VGNC:103619 |
| Mus musculus | CYP19A1 | MGD | MGI:88587 |
| Canis familiaris | CYP19A1 | VGNC | VGNC:50331 |
| Others | CYP19A1 | NCBI |